Madison, Caitlin Lecturer

academic article

• Debler, R. A., Madison, C. A., Hillbrick, L., Gallegos, P., Safe, S., Chapkin, R. S., & Eitan, S. (2023). Selective aryl hydrocarbon receptor modulators can act as antidepressants in obese female mice. JOURNAL OF AFFECTIVE DISORDERS.  333, 409-419.
  
• Madison, C. A., Hillbrick, L., Kuempel, J., Albrecht, G. L., Landrock, K. K., Safe, S., Chapkin, R. S., & Eitan, S. (2023). Intestinal epithelium aryl hydrocarbon receptor is involved in stress sensitivity and maintaining depressive symptoms. Behavioural Brain Research.  440, 114256-114256.
  
• Madison, C. A., Debler, R. A., Vardeleon, N. I., Hillbrick, L., Jayaraman, A., Safe, S., Chapkin, R. S., & Eitan, S. (2022). Sex-dependent differences in the stress mitigating and antidepressant effects of selective aryl hydrocarbon receptor modulators. JOURNAL OF AFFECTIVE DISORDERS.  319, 213-220.
  
• Madison, C. A., Kuempel, J., Albrecht, G. L., Hillbrick, L., Jayaraman, A., Safe, S., Chapkin, R. S., & Eitan, S. (2022). 3,3'-Diindolylmethane and 1,4-dihydroxy-2-naphthoic acid prevent chronic mild stress induced depressive-like behaviors in female mice. JOURNAL OF AFFECTIVE DISORDERS.  309, 201-210.
  
• Chen, J., Yuan, M., Madison, C. A., Eitan, S., & Wang, Y. a. (2022). Blood-brain barrier crossing using magnetic stimulated nanoparticles. Journal of Controlled Release.  345, 557-571.
  
• Eitan, S., Madison, C. A., & Kuempel, J. (2021). The self-serving benefits of being a good host: A role for our micro-inhabitants in shaping opioids' function. Neuroscience and Biobehavioral Reviews.  127, 284-295.
  
• Madison, C. A., Arora, M., Kumar, M., & Eitan, S. (2020). Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in Mice. ACS Chemical Neuroscience.  11(13), 1955-1964.
  
• Madison, C. A., Wellman, P. J., & Eitan, S. (2020). Pre-exposure of adolescent mice to morphine results in stronger sensitization and reinstatement of conditioned place preference than pre-exposure to hydrocodone. JOURNAL OF PSYCHOPHARMACOLOGY.  34(7), 771-777.
  
• Madison, C. A., & Eitan, S. (2020). Buprenorphine: prospective novel therapy for depression and PTSD. Psychological Medicine.  50(6), 881-893.
  
• Madison, C. A., Wellman, P. J., & Eitan, S. (2020). Response to opioids is dependent on sociability levels. BEHAVIOURAL PHARMACOLOGY.  31(2&3), 293-307.
  
• Malin, D. H., Henceroth, M. M., Elayoubi, J., Campbell, J. R., Anderson, A., Goyarzu, P., ... Burstein, E. S. (2018). A subtype-specific neuropeptide FF receptor antagonist attenuates morphine and nicotine withdrawal syndrome in the rat. NEUROSCIENCE LETTERS.  684, 98-103.
  
• Malin, D. H., Henceroth, M. M., Izygon, J. J., Nghiem, D. M., Moon, W. D., Anderson, A. P., ... Burstein, E. S. (2015). Reversal of morphine tolerance by a compound with NPFF receptor subtype-selective actions. NEUROSCIENCE LETTERS.  584, 141-145.